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Hollow mesoporous nanomaterial is a kind of promising new drug delivery system due to their unique hollow structures. In order 
to evaluate the toxicity of silica nanorattle (SN) particles in vivo, 40 female mice were used in this study to investigate the acute tox-
icity and oxidative damage. Mice were intravenously injected with SN suspension in sterile 5% glucose at 40, 80 and 240 mg/kg, 
respectively. The control group was administrated with equal-volume 5% glucose. Weight, feed intake, hematology analysis, 
blood biochemical assay and histopathology diagnosis were examined. The activities of SOD, GSH and CAT were measured as 
well. The results demonstrated that the levels of ALT and AST in the mice treated with 240 mg/kg SN increased significantly as 
compared with the control group (P<0.05), whereas the contents of BUN and CREA changed unremarkably. The activity of SOD 
induced by SN in the liver decreased significantly (P<0.05). In summary, this study revealed that liver was the target organ of the 
SN. It also can be concluded that activity of SOD played an important role in liver injury caused by SN.  
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In the past few years, mesoporous nanomaterials have at-
tracted more and more attention owing to their great poten-
tial application in many fields, such as physics, chemistry 
and textile, especially in biomedicine [1–5]. Mesoporous 
silica has been extensively explored as drug carriers due to 
their unique mesoporous structures and large surface area 
[6]. However, the drug storage capacity of the conventional 
mesoporous materials is relatively low, and the uneven 
morphology of them is not optimal for drug delivery. To 
overcome these problems, one strategy is to synthesize 
mesoporous hollow silica nanoparticles with penetrating 
pore channels from outside to the inner hollow capacity [7]. 
However, for synthesizing nanomaterials with hollow struc-
ture, the fabrication processes are often so tedious that they 
are difficult to be scaled up. Recently, we reported a flexible, 
scalable and robust method to prepare rattle-type mesopo-
rous silica hollow spheres. Compared to conventional meth-
ods used for preparing rattle-type nanomaterials, our selec-
tive etching strategy has many obvious advantages: it is a 
scalable and general method to fabricate functional nano-
particles with significant monodispersion [1]. The silica 
nanorattle with special structures provides a large interstitial 
hollow space to achieve high drug loading amount and mul-
tistage drug release, suggesting potential applications in the 
fields of targeted tumor therapy and imaging in vivo [4,8,9]. 
With the increasing application of mesoporous hollow 
nanoparticles in biomedicine, the concerns on the biosafty 
aspect caused by mesoporous nanoparticles are also in-
creasing [10–12]. So far, most of the researches were fo-
cused on in vitro study [13]. Only a few in vivo studies have 
been concentrated on the toxicity in respiratory system [14]. 
With the rapid development of mesoporous silica in the 
biomedical application, especially as drug carriers, meso-
porous silica may enter the body through intravenous injec-
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tion, subcutaneous injection and so on [8,15]. However, the 
biological effect and biodistribution caused by the mesopo-
rous silica particles exposed through these routes have not 
been sufficiently understood.  
In this paper, the toxicity of silica nanorattle (SN) parti-
cles in vivo after intravenous administration was systemati-
cally evaluated. The potential roles of oxidative stress in the 
damage caused by SN were also investigated. 
1  Materials and methods 
1.1  Materials 
SN was provided by Laboratory of Controllable Preparation 
and Application of Nanomaterials, Technical Institute of 
Physics and Chemistry, Chinese Academy of Sciences [1]. 
Ethanol and glucose was purchased from Beijing Chemical 
Works. Formaldehyde solution were obtained from West 
Long Chemical Indrustries Co., Ltd. Paraffin (melting point, 
50–52°C and 52–54°C) were obtained from Shanghai chem-
ical Industries Co., Ltd. Paraplast® embedding media was 
purchased from sigma (Sigma-Aldrich, St.Louis, MO, USA). 
Glutathione (GSH), malondialdehyde (MDA), total antiox-
idant capacity (T-AOC), catalase (CAT), inducible nitric oxide 
synthase (iNOS) and superoxide dismutase (SOD) assay 
kits were provided by Nan Jing Jian Cheng Bioengineering 
Institute.  
1.2  Preparation and characterization of SN 
SN was soaked in 75% ethanol for 4 h and washed with 
sterile ultrapure water for 3 times. Then they were dispersed 
in sterile 5% glucose solution. Lastly, SN suspension was 
sterilized by UV irradiation for 30 min and sonicated for  
15 min before use. The hydrodynamic diameter and Zeta 
potential of SN in the solution (1 mg/mL) were investigated 
at 25°C with Zetasizer 3000HS (Malvern). Morphology and 
structure of SN were observed with JEOL-200CX transmis-
sion electron microscope (TEM).  
1.3  Animals treatments 
All animal experiments were preformed in compliance with 
the local ethics committee. Forty female ICR mice (ob-
tained from Vital River Laboratory Animal Technology Co. 
Ltd.), aged 6–8 weeks and weighted 20–22 g, were used in 
the study. Mice were randomly divided into four groups (n= 
10 for each group). The animals were intravenously injected 
with SN suspension in sterile 5% glucose at 40, 80 and 240 
mg/kg, respectively. Mice in control group were injected 
with equal-volume 5% glucose.  
1.4  Clinical observation 
Clinical manifestations of the mice were observed intimately 
after dosing SN suspension at different levels. After intra-
venous injection, mortality, animal feed intake and body 
weight were recorded every day. 
1.5  Hematology analysis and serum biochemical assays 
After injection for 14 d, blood was drawn from orbital an-
gular vein blood (0.1 mL) with potassium EDTA collection 
tube for hematology analysis. Blood samples, which were 
collected via the ocular vein (about 0.8–1.0 mL each mouse), 
were centrifuged at 3000 r/min for 20 min in order to sepa-
rate serum. 
1.6  Histopathological assays 
Mice were sacrificed at 14 d after administration, and the 
following organs were collected: liver, spleen, lung, kidney, 
heart and brain. Then these tissues were fixed in 10% neu-
tral formalin, embedded in paraffin, sectioned and stained 
with hematoxylin and eosin (HE) for histological examina-
tion using standard techniques. The slides were observed, 
and photos were taken using an optical microscope (Nikon 
Eclipese Ti-S). 
1.7  Oxidative damage analysis 
After mice had been sacrificed, a portion of liver was frozen 
for detecting oxidative damage indicators. SOD, MDA, 
T-AOC, CAT, iNOS and GSH were tested according to the 
product instructions. 
1.8  Statistics analysis  
Results were expressed as mean ± standard deviation ( x ± s). 
Multigroup comparisons of the means were carried out   
by one-way analysis of variance ANOVA test using SPSS 
17.0 software. P<0.05 was considered statistically signifi-
cant. 
2  Results 
2.1  Characterization of SN 
TEM image and size distribution of SN suspension in sterile 
5% glucose are shown in Figure 1. The well-dispersed SN 
possessed an obvious hollow structure with a movable core. 
The average diameter of the SN from TEM image was de-
termined to be 110±10 nm. And the hydrodynamic diameter 
of the SN in sterile 5% glucose was 180±55 nm, as shown 
in Figure 1(b). The SN had a positive -potential of about 
37.2±1.48 mV. 
2.2  Clinical observation 
In the period of experiments, no distinctive changes in general  
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Figure 1  TEM image (a) and the size distribution (b) of SN in sterile 5% glucose. Scale bar is 50 nm.  
behavior involving feed intake, water-drinking, reflection 
action, respiration and body temperature were observed in 
the experimental groups compared with the control. No 
deaths were observed in the treatment groups. The average 
daily feed intake (ADFI) and body weight of the treated 
mice showed insignificant changes as compared with the 
control group (P>0.05), as revealed in Figure 2.   
2.3  Hematology analysis 
Representative hematology markers were analyzed, includ-
ing red blood cell count (RBC), hemoglobin (HGB), hema-
tocrit (HCT), mean corpuscular hemoglobin concentration 
(MCHC), mean corpuscular volume (MCV), mean corpus-
cular hemoglobin (MCH), platelet count (PLT) and white 
blood cell count (WBC). In contrast to the control group, all 
hematology makers were not significantly affected after 
administration of SN at 40, 80 and 240 mg/kg (P>0.05) 
(Figure 3). 
2.4  Serum biochemical assay 
Representative serum biochemical indicators involving ala-
nine aminotransferase (ALT), aspartate aminotransferase 
(AST), urea nitrogen (BUN) and creatinine (CREA) were 
detected as well. The contents of serum ALT or AST were 
significantly increased with SN administration at 240 mg/kg, 
while no significant increase was observed with that at 40 
and 80 mg/kg as compared with the control group (P<0.05) 
(Figure 4(a),(b)). However, BUN and CREA level changed 
unremarkably after injecting SN at 40, 80 and 240 mg/kg 
(Figure 4(c),(d)). 
2.5  Histopathological examinations 
The paraffin slices of representative organs including liver, 
spleen, lung, kidney, heart and brain were prepared. And the 
morphology changes of these organs were analyzed. Com-
pared with the control group, there were no apparent histo-
pathological abnormalities or lesions. The cell nucleus was 
bright and the cytoplasm was abundant for the groups 
treated with SN at 40 and 80 mg/kg (Figure 5(b)). But lym-
phocytic infiltration and swelling in liver were obviously 
observed at the group after administration at 240 mg/kg, as 
shown in Figure 5(c). Spleen samples obtained from the 
treatment groups showed no significant changes, and the 
size of the red pulp was well-defined as compared with that 
of the control group (Figure 5(e), (f)). Kidney, heart, lung, 
and brain samples also showed no remarkable change in the 
morphology, as revealed in Figure 5(g)–(i) and Figure 6(a)–(i). 
2.6  Oxidative damage 
Oxidative stress is considered to be one of the key mecha-     
 
Figure 2  The change of average daily feed intake (a) and body weight (b) obtained from mice injected at different doses of SN. SN-40, SN-80 and SN-240 
represent the dose of SN at 40, 80 and 240 mg/kg, respectively.  
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Figure 3  Effect of different doses of SN on hematology at 14 d. (a)–(h) are red blood cell count (RBC), hemoglobin (HGB), hematocrit (HCT), mean 
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet count (PLT) and white 
blood cell count (WBC), respectively.  
nisms for the toxicity of nanomaterials. In this paper, anti- 
oxidative indicators of the liver were detected. The results 
are shown in Figure 7. It can be observed that the activity of 
SOD in the treatment groups decreased significantly (P<0.05). 
However, there was no significant difference between that 
of the three groups treated with SN, as summarized in Fig-
ure 7(a). The content of GSH and MDA showed no signifi-
cant variation in the groups treated with SN at 40, 80 and 
240 mg/kg as well (Figure 7(b), (e)). The activity of CAT 
had a trend to increase in the treatment groups, but it was 
not significant (P>0.05). And the activity of iNOS in the 
group dosed at 80 mg/kg was also slightly elevated. Never-
theless, iNOS of the groups treated at 40 and 240 mg/kg 
decreased instead. But the change was not significant 
(P>0.05), as shown in Figure 7(f). 
3  Discussion 
Very recently, several studies have demonstrated that SN 
particles not only can serve as promising drug carriers for 
high tumor targeting efficiency and therapy efficacy, but  
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Figure 4  Effect of different doses of SN on serum biochemistry at 14 d. (a)–(d) are alanine aminotransferase (ALT), aspartate aminotranferase (AST), 
creatinine (CREA) and blood urea nitrogen (BUN), separately. * denotes statistical significance for the comparison of control, P<0.05.  
 
Figure 5  Histological analyses of liver ((a)–(c)), spleen ((d)–(f)) and kidney ((g)–(i)) from mice injected with SN at control group ((a), (d), (g)), 40 mg/kg 
((b), (e), (h)) and 240 mg/kg ((c), (f), (i)), arrows indicates the infiltration. Scale bar is 100 m.  
also for reducing the systematic toxicity [16,17]. However, 
the biological safety effect is sill being a pendent question 
of SN particles [18,19]. Therefore, the toxicity of SN in vivo 
exposed by intravenous injection was evaluated in this study. 
We found that exposure of SN at 40 and 80 mg/kg would 
not affect the value of hematologic markers, serum bio-
chemical markers compared with the control group, which 
indicates that SN would not induce evident adverse effects   
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Figure 6  Histological analyses of heart ((a)–(c)), lung ((d)–(f)) and brain ((g)–(i)) from mice injected with SN at control group ((a), (d), (g)), 40 mg/kg ((b), 
(e), (h)) and 240 mg/kg ((c), (f), (i)). Scale bar is 100 m.  
 
Figure 7  The change of oxidative stress induced by different doses of SN through tail intravenous injection. * denotes statistical significance in comparison with 
control, P<0.05. (a)–(f) are superoxide dismutase (SOD), glutathione (GSH), catalase (CAT), total antioxidant capacity (T-AOC), malondialdehyde (MDA) 
and inducible nitric oxide synthase (iNOS), respectively. 
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at dose of 40 and 80 mg/kg. 
The obvious elevation of blood biochemical indexes and 
the significant variation in the histopathology of liver tissue 
were observed at 240 mg/kg dose. The predominant in-
crease in ALT and AST of the mice was caused by the in-
jection of high dose of SN. ALT and AST are important 
aminotransferases in the body. ALT is mainly distributed in 
the liver, kidney and heart and so on. And the highest con-
centration of AST is found in heart, liver, skeleton muscle 
and kidney [20]. Both ALT and AST can be released into 
the blood when these tissues are injured. As a result, the 
contents of ALT and AST in the blood would increase sig-
nificantly. Thus, the changes of ALT and ASL in blood of-
fer important references as probes of damages to the heart 
and liver [21,22]. We found that administration of high-dose 
SN obviously increased ALT and AST contents but would 
not cause any abnormalities of heart. It caused inflammation 
to the liver, which means the increase of transaminase indi-
cators are caused by liver injury. In addition, the histomor-
phology studies suggest that injection of SN at 240 mg/kg 
would not cause damages to spleen, kidney, lung and brain. 
Thus, liver is to be the major organ for toxicity by the in-
travenous administration of the SN particles. 
Oxidative damage to the cells and tissues induced by 
nanomaterials has attracted broad attention. It is considered 
to be one of the key mechanisms in the toxicity of nano-
materials [23]. Oxidative damage is the result of unbalance 
between the oxidant and antioxidant processes. Antioxidant 
defense system plays an important role in the elimination of 
oxygen radical in vivo, which includes enzymatic scaven-
gers (SOD, CAT and GPX) and some small-molecule anti-
oxidants (GSH, vitamin C and vitamin E) [24]. Here, we 
investigated the antioxidant defense system involving the 
index of SOD, CAT, GSH, and so on. The results showed 
that the activity of SOD was decreased after intravenous 
injection of SN, and no significant changes of other indica-
tors were detected in mice hepatocytes. It may be related to 
the important role of SOD in the antioxidant system in vivo, 
because SOD is the unique antioxidant enzyme for scav-
enging superoxide anion in the body [25]. It has been sug-
gested that SN could trigger the generation of reactive oxy-
gen species (ROS), which results in injuries of the tissues 
[26]. A large amount of SOD was consumed to diminish 
ROS level, which results in disturbance of the balance be-
tween the oxidant and antioxidant process [27]. Thus, this 
study reminds us that the damages to the liver may be re-
lated to the decreased activity of SOD caused by SN. It of-
fers us an important basis for further investigating the tox-
icity mechanism of nanomaterials and constructing the cor-
responding strategies for preventions. 
From the above results, no apparent toxic effects were 
observed at low dose of SN, whereas injection of SN at high 
dose would cause some damages to the liver of mice. 
Therefore, through adjusting the dose of drug carriers, it can 
not only obtain a satisfactory therapeutic efficacy, but also 
avoid the toxic effects caused by the carriers. It provides us 
important experimental information for the clinical applica-
tion of SN as nano-drug carriers. 
4  Conclusion 
In conclusion, we demonstrate that the as-prepared SN has 
good biocompatibility, which provides important foundation 
of toxicity research for the exploitation of SN as new drug 
carriers. SN would induce liver damage when exposed at 
high concentration. The injury may be related to the de-
creased activity of SOD. The results offer us useful infor-
mation for the further research on the toxicity mechanism 
caused by nanoparticles. 
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